(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (R)-SDP

Formula: C41H34 P2

CAS: 917377-74-3

Element: diphenylphosphino spirobiindane tetrahydro

Page Content Identification Properties Suppliers Prices & Availability Get Quick Quote ☰

Identification Properties Suppliers Prices & Availability Get Quick Quote

C-S » Chemicals » bis-diphenylphosphino-tetrahydro-spirobiindane-sdp-PX1900525

Identification

Structural Formula

(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (R)-SDP

CAS:

917377-74-3

EINECS:

Molecular Formula:

C₄₁H₃₄ P₂

MDL:

MFCD09991538

Synonym:

(r)-(+)-7,7'-bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (r)-sdp ; (r)-(+)-7,7'-bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindene ; phosphine,1,1'-[(1r)-2,2',3,3'-tetrahydro-1,1'-spirobi[1h-indene]-7,7'-diyl]bis[1,1-diphenyl-(9ci)

Suppliers

Get Quick Quote

CAS equal suppliers

(R)-SDP

Santa Cruz Biotechnology, Inc.

236657

Prices & Availability

Data is processed

x

Properties for (R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (R)-SDP

Molecular Weight:

588.66 g·mol−1

Melting point:

198-203° C

Physical Description:

white to light yellow solid

x

Safety & Transport Information

Storage temperature :

?20 °C

x

Alternative Distributors of [(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (R)-SDP]

Producers or manufacturers change the product range from time to time. Currently there are no other manufacturers known.

x

Downloads

Mol File:

-/-

MSDS:

-/-

Related products

View related products

(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane

(S)-(-)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane

(R)-(+)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane

(S)-(-)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane

(S)-(-)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (S)-SDP

(R)-(+)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane

(S)-(-)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane

(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2',3,3'-tetrahydro-1,1'-spirobiindane

(R)-(+)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (R)-Tol-SDP

(S)-(-)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (S)-Tol-SDP

(R)-(+)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (R)-Xyl-SDP

(S)-(-)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; 97% (S)-Xyl-SDP

(R)-(+)-7'- [4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2',3,3'-tetrahydro-1,1-spirobiindane; 97%, (Ra,S)-DTB-Bn-SIPHOX

(S)-(-)-7'- [4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2',3,3'-tetrahydro-1,1® spirobiindane; 97%, (Sa,S)-DTB-Bn-SIPHOX

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; min. 98% (>99% ee) (R)-DTB-SpiroPAP

(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; min. 98% (>99% ee) (S)-DTB-SpiroPAP

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; min. 98% (>99% ee) (R)-DTB-SpiroPAP-3-Me

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(6-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; min. 98% (>99% ee) (R)-DTB-SpiroPAP-6-Me

(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(3-methylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; min. 98% (>99% ee) (S)-DTB-SpiroPAP-3-Me

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(4-t-butylpyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane; min. 98% (>99% ee) (R)-DTB-SpiroPAP-4-t-Bu

▲

▲